Tumors suppress a mitochondrial chaperone activity in macrophages to facilitate immune evasion 2455

Abstract Description Unlike the dysfunctional mitochondria of tumor-infiltrating T cells, tumor-associated macrophages (TAMs) maintain their functional mitochondria in the nutrient-deprived tumor microenvironment (TME), promoting an immunosuppressive phenotype. However, the mechanisms underlying this remain unclear. Here, we identify that TNF-receptor associated protein-1 (TRAP1), a mitochondrial chaperone, serves as an endogenous metabolic checkpoint that regulates mitochondrial respiration and drives immunosuppressive function in TAMs. In the TME, TRAP1 expression in TAMs is suppressed via the TIM4-AMPK pathway. Using TRAP1-deficient mice, we observed that TRAP1 loss amplifies immunoinhibitory function in macrophages while reducing proinflammatory activity. Mechanistically, TRAP1 absence enhanced activity of mitochondrial electron transport chain complexes and increased the α-ketoglutarate (α-KG) to succinate ratio. The increase in α-KG facilitates JMJD3-mediated histone demethylation, altering genes expression associated with immunosuppressive activation in macrophages and thereby facilitating tumor immune escape. Notably, boosting TRAP1 expression in TAMs disrupts the immunosuppressive TME, bolstering anti-tumor immunity. These findings underscore TRAP1’s pivotal role in TAM metabolic rewiring and immune modulation, highlighting its potential as a therapeutic target in cancer immunotherapy. Funding Sources Supported by American Cancer Society Research Scholar Grant (RSG-22-135-01-IBCD), Melanoma Research Foundation Career Development Award, Andrew McDonough B+ Foundation Grant Award, Cancer Research Institute CLIP Investigator Award, Case Comprehensive Cancer Center American Cancer Society Pilot Grants (IRG-91-022-19, IRG-16-186-21). Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.371
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumors suppress a mitochondrial chaperone activity in macrophages to facilitate immune evasion 2455

Zihai Li, Lydia Raines, Wei Cao, Alex Y. Huang et al.
The Journal of Immunology
Immune cells in cancer
article

Tumors suppress a mitochondrial chaperone activity in macrophages to facilitate immune evasion 2455

Zihai Li, Lydia Raines, Wei Cao, Alex Y. Huang, Jaeoh Park, Chan‐Wang Jerry Lio, Ping‐Chih Ho, Stanley Ching‐Cheng Huang, Haoxin Zhao, Yuli Ouyang, Michael Hsu, Heng-Yi Chen, Yuzhu Wang
article en

Abstract

Abstract Description Unlike the dysfunctional mitochondria of tumor-infiltrating T cells, tumor-associated macrophages (TAMs) maintain their functional mitochondria in the nutrient-deprived tumor microenvironment (TME), promoting an immunosuppressive phenotype. However, the mechanisms underlying this remain unclear. Here, we identify that TNF-receptor associated protein-1 (TRAP1), a mitochondrial chaperone, serves as an endogenous metabolic checkpoint that regulates mitochondrial respiration and drives immunosuppressive function in TAMs. In the TME, TRAP1 expression in TAMs is suppressed via the TIM4-AMPK pathway. Using TRAP1-deficient mice, we observed that TRAP1 loss amplifies immunoinhibitory function in macrophages while reducing proinflammatory activity. Mechanistically, TRAP1 absence enhanced activity of mitochondrial electron transport chain complexes and increased the α-ketoglutarate (α-KG) to succinate ratio. The increase in α-KG facilitates JMJD3-mediated histone demethylation, altering genes expression associated with immunosuppressive activation in macrophages and thereby facilitating tumor immune escape. Notably, boosting TRAP1 expression in TAMs disrupts the immunosuppressive TME, bolstering anti-tumor immunity. These findings underscore TRAP1’s pivotal role in TAM metabolic rewiring and immune modulation, highlighting its potential as a therapeutic target in cancer immunotherapy. Funding Sources Supported by American Cancer Society Research Scholar Grant (RSG-22-135-01-IBCD), Melanoma Research Foundation Career Development Award, Andrew McDonough B+ Foundation Grant Award, Cancer Research Institute CLIP Investigator Award, Case Comprehensive Cancer Center American Cancer Society Pilot Grants (IRG-91-022-19, IRG-16-186-21). Topic Categories Tumor Immunology: Cellular Responses and Tumor Microevironment (TIME)

The Journal of ImmunologyVol. 214(Supplement_1)
The Ohio State University (US), Case Western Reserve University (US), University of Lausanne (CH)
Health and Medical Research Fund
Openalex Percentile: Top 61%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.